Considering the cited low postnatal IGF-1 concentrations in preterm infants, associated to ROP and other complications, a supplementation with recombinant human IGF-1 and its binding protein rhIGFBP-3 has been suggested (47). The gene discussed is IGF1; the disease is retinopathy of prematurity.